ATP Non-Competitive Ser/Thr Kinase Inhibitors as Potential Anticancer Agents

被引:15
作者
Cozza, Giorgio [1 ,2 ]
Bortolato, Andrea [1 ]
Menta, Ernesto [3 ]
Cavalletti, Ennio [3 ]
Spinelli, Silvano [3 ]
Moro, Stefano [1 ]
机构
[1] Univ Padua, Dipartimento Sci Farmaceut, MMS, I-35131 Padua, Italy
[2] Univ Padua, Dipartimento Chim Biol, I-35121 Padua, Italy
[3] Eth Oncol Sci SpA, I-20121 Milan, Italy
关键词
Ser/Thr kinase inhibitors; ATP non-competitive; anticancer drugs; drug discovery; 2,3,5-TRISUBSTITUTED PYRIDINE-DERIVATIVES; ORAL MEK INHIBITOR; MAP KINASE; IN-VITRO; PROTEIN; ACTIVATION; DISCOVERY; CI-1040; JNK; IDENTIFICATION;
D O I
10.2174/187152009789056930
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Protein kinases are one of the largest known families of enzyme characterized by having a well conserved ATP binding pocket. Most of the synthetic kinase inhibitors are ATP-competitive, but display some potential problems, like selectivity, discrepancy between the in vitro and in vivo inhibition assays and an high risk of developing mutation inside the ATP-binding pocket. Recently some new inhibitors with a non-competitive mechanism of action were reported, with intresting results both in vitro and in vivo.
引用
收藏
页码:778 / 786
页数:9
相关论文
共 41 条
[1]   PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO [J].
ALESSI, DR ;
CUENDA, A ;
COHEN, P ;
DUDLEY, DT ;
SALTIEL, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27489-27494
[2]   The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901 [J].
Barrett, Stephen D. ;
Bridges, Alexander J. ;
Dudley, David T. ;
Saltiel, Alan R. ;
Fergus, James H. ;
Flamme, Cathlin M. ;
Delaney, Amy M. ;
Kaufman, Michael ;
LePage, Sophie ;
Leopold, Wilbur R. ;
Przybranowski, Sally A. ;
Sebolt-Leopold, Judith ;
Van Becelaere, Keri ;
Doherty, Annette M. ;
Kennedy, Robert M. ;
Marston, Dan ;
Howard, W. Allen, Jr. ;
Smith, Yvonne ;
Warmus, Joseph S. ;
Tecle, Haile .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (24) :6501-6504
[3]   Oncogenic kinase signalling [J].
Blume-Jensen, P ;
Hunter, T .
NATURE, 2001, 411 (6835) :355-365
[4]   Therapeutic promise of JNK ATP-noncompetitive inhibitors [J].
Bogoyevitch, MA .
TRENDS IN MOLECULAR MEDICINE, 2005, 11 (05) :232-239
[5]   BMS-345541 is a highly selective inhibitor of IκB kinase that binds at an allosteric site of the enzyme and blocks NF-κB-dependent transcription in mice [J].
Burke, JR ;
Pattoli, MA ;
Gregor, KR ;
Brassil, PJ ;
MacMaster, JF ;
McIntyre, KW ;
Yang, XX ;
Iotzova, VS ;
Clarke, W ;
Strnad, J ;
Qiu, YP ;
Zusi, FC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) :1450-1456
[6]   Role of a Novel PH-Kinase Domain Interface in PKB/Akt Regulation: Structural Mechanism for Allosteric Inhibition [J].
Calleja, Veronique ;
Laguerre, Michel ;
Parker, Peter J. ;
Larijani, Banafshe .
PLOS BIOLOGY, 2009, 7 (01) :189-200
[7]  
CHOW L, 2005, P AACR EORTC NCI TAR, pC162
[8]   Development of thioquinazolinones, allosteric Chk1 kinase inhibitors [J].
Converso, Antonella ;
Hartingh, Timothy ;
Garbaccio, Robert M. ;
Tasber, Edward ;
Rickert, Keith ;
Fraley, Mark E. ;
Yan, Youwei ;
Kreatsoulas, Constantine ;
Stirdivant, Steve ;
Drakas, Bob ;
Walsh, Eileen S. ;
Hamilton, Kelly ;
Buser, Carolyn A. ;
Mao, Xianzhi ;
Abrams, Marc T. ;
Beck, Stephen C. ;
Tao, Weikang ;
Lobell, Rob ;
Sepp-Lorenzino, Laura ;
Zugay-Murphy, Joan ;
Sardana, Vinod ;
Munshi, Sanjeev K. ;
Jezequel-Sur, Sylvie Marie ;
Zuck, Paul D. ;
Hartman, George D. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (04) :1240-1244
[9]   Design, Synthesis, and Structure-Activity Relationship of Substrate Competitive, Selective, and in Vivo Active Triazole and Thiadiazole Inhibitors of the c-Jun N-Terminal Kinase [J].
De, Surya K. ;
Stebbins, John L. ;
Chen, Li-Hsing ;
Riel-Mehan, Megan ;
Machleidt, Thomas ;
Dahl, Russell ;
Yuan, Hongbin ;
Embadi, Aras ;
Barile, Elisa ;
Chen, Vida ;
Murphy, Ria ;
Pellecchia, Maurizio .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (07) :1943-1952
[10]   Identification of a novel mitogen-activated protein kinase kinase activation domain recognized by the inhibitor PD 184352 [J].
Delaney, AM ;
Printen, JA ;
Chen, HF ;
Fauman, EB ;
Dudley, DT .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (21) :7593-7602